Similar articles

• Studies on the composition of adjuvants which selectively enhance delayed-type hypersensitivity to lipid conjugated protein antigens.

  Champlin R, Hunter RL. Champlin R, et al. J Immunol. 1975 Jan;114(1 Pt 1):76-80. J Immunol. 1975. PMID: 1089714
• Immunological adjuvants. V. A critical evaluation of minimal requirements for mycobacterial adjuvants to induce delayed hypersensitivity.

  Ishibashi T, Hagimoto D, Shinozaki S, Tanaka A, Sugiyama K. Ishibashi T, et al. Jpn J Exp Med. 1971 Apr;41(2):95-102. Jpn J Exp Med. 1971. PMID: 4994872 No abstract available.
• Immunological adjuvants. I. Adjuvant activity and immunogenicity of acetylated wax D and its subfractions.

  Tanaka K, Tanaka A, Sugiyama K. Tanaka K, et al. Int Arch Allergy Appl Immunol. 1968;34(5):495-506. Int Arch Allergy Appl Immunol. 1968. PMID: 4972181 No abstract available.
• [Purification and application of tuberculosis adjuvants].

  Tanaka A. Tanaka A. Nihon Rinsho. 1974 Jul 10;32(7):2518-25. Nihon Rinsho. 1974. PMID: 4215911 Review. Japanese. No abstract available.
• Nonliving immunogenic substances of Mycobacteria.

  Smith DW, Grover AA, Wiegeshaus E. Smith DW, et al. Bibl Tuberc. 1968;24:191-227. Bibl Tuberc. 1968. PMID: 4983194 Review. No abstract available.